Norman L. Block

7.7k citations

194 papers · 6.0k indexed · h-index 41

Impact in

Endocrinology, Diabetes and Metabolism top 0.5%
- Growth Hormone and Insulin-like Growth Factors
- Hormonal and reproductive studies
Urology top 1%

Papers in

Endocrinology, Diabetes and Metabolism 52
- Growth Hormone and Insulin-like Growth Factors 27
- Hormonal and reproductive studies 20
Urology 14

Co-authors: Andrew V. Schally Vinata B. Lokeshwar Bal L. Lokeshwar Mark S. Soloway Ferenc G. Rick Henri T. Pham Marie G. Selzer Luca Szalontay
Journals: The Journal of Urology (29 papers)Proceedings of the National Academy of Sciences (23 papers)Urology (17 papers)The Prostate (9 papers)Oncotarget (9 papers)
Partner nations: United States Germany Hungary

In The Last Decade

Norman L. Block

190 papers receiving 5.8k citations

Peers

Countries citing papers authored by Norman L. Block

Since Specialization

Citations

This map shows the geographic impact of Norman L. Block's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norman L. Block with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norman L. Block more than expected).

Fields of papers citing papers by Norman L. Block

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Norman L. Block. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norman L. Block. The network helps show where Norman L. Block may publish in the future.

Co-authors

The 25 scholars most cited alongside Norman L. Block, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Norman L. Block Line = papers co-authored together Norman L. Block links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Role of growth hormone-releasing hormone in dyslipidemia associated with experimental type 1 diabetes Proceedings of the National Academy of Sciences ·Maritza J. Romero, Rudolf Lucas, Huijuan Dou, Supriya Sridhar, István Czikora, Danlin Luo, Ferenc G. Rick, Norman L. Block, Subbaramiah Sridhar, David Fulton, Neal L. Weintraub, Zsolt Bagi, Andrew V. Schally	2016	14
2	LHRH receptor expression in sarcomas of bone and soft tissue Hormone Molecular Biology and Clinical Investigation ·Myoung H. Park, H. Thomas Temple, Norman L. Block, Philip Robinson, Andrew V. Schally	2016	2
3	The Role of the FSH System in the Development and Progression of Prostate Cancer E. David Crawford, Kyle O. Rove, Andrew V. Schally, Ferenc G. Rick, Norman L. Block, Thomas J.R. Beveridge, 晴行小久保, Dennis C. Marshall	2014	15
4	Protective effect of Growth Hormone-Releasing Hormone agonist in bacterial toxin-induced pulmonary barrier dysfunction Frontiers in Physiology ·István Czikora, Supriya Sridhar, Boris Gorshkov, Irina B. Alieva, 幸子円山, Joaquin U. Gonzales, Funmi Grace Onome Oni, Nagavedi S. Umapathy, Helena Pillich, Ferenc G. Rick, Norman L. Block, Alexander D. Verin, Trinad Chakraborty, Michael A. Matthay, Andrew V. Schally, Rudolf Lucas	2014	22
5	Modulation of the Pancreatic Islet-Stress Axis as a Novel Potential Therapeutic Target in Diabetes Mellitus Vitamins and hormones ·Barbara Ludwig, Andreas Barthel, Andreas Reichel, Norman L. Block, Stefan Ludwig, Andrew V. Schally, Stefan R. Bornstein	2014	6
6	Antagonists of growth hormone-releasing hormone suppress in vivo tumor growth and gene expression in triple negative breast cancers Oncotarget ·Roberto Pérez‐Castañeda, Andrew V. Schally, Irving Vidaurre, H. Liu, Norman L. Block, Ferenc G. Rick	2012	43
7	Search for novel therapies for triple negative breast cancers (TNBC): analogs of luteinizing hormone-releasing hormone (LHRH) and growth hormone-releasing hormone (GHRH) Hormone Molecular Biology and Clinical Investigation ·Stefan Buchholz, Stephan Seitz, J. Engel, Ms.Christy James, Olaf Ortmann, Roberto Pérez‐Castañeda, Norman L. Block, Andrew V. Schally	2012	4
8	Combination of gastrin-releasing peptide antagonist with cytotoxic agents produces synergistic inhibition of growth of human experimental colon cancers Cell Cycle ·Ferenc G. Rick, Stefan Buchholz, Andrew V. Schally, Luca Szalontay, Awtar Krishan, Christian Datz, Andreas Stadlmayr, Elmar Aigner, Roberto Pérez‐Castañeda, Stephan Seitz, Norman L. Block, Florian Hohla	2012	23
9	Inhibitory Effects of GHRH Antagonists on Human GH-Secreting Adenoma Tissue Neuroendocrinology ·Luca Szalontay, Ronald J. Benveniste, Andrew V. Schally, Irving Vidaurre, Mehrdad Nadji, Márta Zarándi, Norman L. Block, Magdolna Kovács	2012	5
10	Growth Hormone-Releasing Hormone Receptor Splice Variant 1 is Frequently Expressed in Oral Squamous Cell Carcinomas Hormones and Cancer ·Nikolina Dioufa, Elena Farmaki, Andrew V. Schally, Hippokratis Kiaris, Monica Marín-Domínguez, Athanasios G. Papavassiliou, Christos Kittas, Norman L. Block, Ioulia Chatzistamou	2012	5
11	Hormonal manipulation of benign prostatic hyperplasia Current Opinion in Urology ·Ferenc G. Rick, Seyed Hassan Saadat, Luca Szalontay, Norman L. Block, Amir Kazzazi, Bob Djavan, Andrew V. Schally	2012	16
12	Novel antagonists of growth hormone‐releasing hormone inhibit growth and vascularization of human experimental ovarian cancers Cancer ·Anna Klukovits, Andrew V. Schally, Luca Szalontay, Irving Vidaurre, Andrea Papadia, Márta Zarándi, József L. Varga, Norman L. Block, Gábor Halmos	2011	30
13	The use of peptide analogs for the treatment of gastrointestinal, pancreatic, liver and urinary bladder cancers Hormone Molecular Biology and Clinical Investigation ·Károly Szepesházi, Norman L. Block, Andrew V. Schally	2009	2
14	A Renal Protocol for All Ages and All Indications: Mercapto-Acetyl-Triglycine (MAG3) With Simultaneous Injection of Furosemide (MAG3-F0): A 17-Year Experience Seminars in Nuclear Medicine ·George N. Sfakianakis, Efrosyni Sfakianaki, N. Rivier, Aldo N. Serafini, D A Tikhomirov, Russ Kuker, Gastón Zilleruelo, José Strauss, Carolyn Abitbol, Jayanthi Chandar, Wacharee Seeherunvong, 孟庆木, David Roth, Raymond J. Leveillee, Vincent G. Bird, Norman L. Block, Rafael Gosálbez, Andrew Labbie, Jorge J. Llibre Guerra, José Yrizarry	2009	21
15	Her2 expression in prostatic cancer: a comparison with mammary carcinoma. PubMed ·Mercè Jordà, Rego Fp, Zeina Ghorab, Deylami Ahmad, Mehrdad Nadji, Norman L. Block	2002	32
16	Clinical benefits of bicalutamide compared with flutamide in combined androgen blockade for patients with advanced prostatic carcinoma: Final report of a double-blind, randomized, multicenter trial Urology ·Paul F. Schellhammer, Roohollah Sharifi, Norman L. Block, Mark S. Soloway, Peter Venner, Anthony L. Patterson, Michael F. Sarosdy, Nicholas J. Vogelzang, Zhuo Xiangrong, Geert J.C.M. Kolvenbag	1997	123
17	Expression of prostatic TRH‐like peptides differs between species and between malignant and nonmalignant tissues The Prostate ·Peter J. Gkonos, Carol S. Mehlman, Norman L. Block, Bernard A. Roos	1993	17
18	Interaction of irradiation and microwave-induced hyperthermia in the Dunning R3327G prostatic adenocarcinoma model. Radiology ·桜井和夫, G. Burton Seibert, Norman L. Block	1988	12
19	Flow cytometric monitoring of prostatic carcinoma. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·C. Bruce Bagwell, Norman L. Block, Massimiliano Pingue	1979	5
20	The initiation, progress, and diagnosis of dog bladder cancer induced by 4-aminobiphenyl. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·Norman L. Block, M. Michael Sigel, Charles M. Lynne, 延行石綿, D.S. Savkov	1978	12

About Norman L. Block

Norman L. Block is a scholar working on Endocrinology, Diabetes and Metabolism, Urology, Pulmonary and Respiratory Medicine, Oncology and Rheumatology, having authored 194 papers that have together received 6.0k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (38 papers), Growth Hormone and Insulin-like Growth Factors (27 papers), Prostate Cancer Diagnosis and Treatment (21 papers), Hormonal and reproductive studies (20 papers), Estrogen and related hormone effects (16 papers), Urologic and reproductive health conditions (16 papers), Cancer-related Molecular Pathways (14 papers) and Bladder and Urothelial Cancer Treatments (12 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.5k citations), Urology (359 citations), Pulmonary and Respiratory Medicine (1.7k citations), Cancer Research (684 citations) and Cell Biology (733 citations). Norman L. Block has collaborated with scholars based in United States, Germany and Hungary. Frequent co-authors include Andrew V. Schally, Vinata B. Lokeshwar, Bal L. Lokeshwar, Mark S. Soloway, Ferenc G. Rick, Henri T. Pham, Marie G. Selzer, Luca Szalontay, Mehrdad Nadji and Can Öbek. Their work appears in journals such as The Journal of Urology, Proceedings of the National Academy of Sciences, Urology, The Prostate and Oncotarget.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact